The development of malignancy after a successful kidney transplant poses unique challenges. The most common malignancies after kidney transplantation are skin cancers. Hematologic cancers are usually post transplant lymphoproliferative disorders (PTLD). Although studies have shown that certain cancers are more likely to occur in patients with CKD or with ESRD, the overall incidence of cancer clearly increases further after kidney transplantation.
Nephron Sparing Surgery vs Tyrosine Kinase Inhibitor Toxicity Winner: Tyrosine Kinase Inhibitor Toxicity 4-3 split In another narrow victory, Team Tyrosine Kinase moves to the sweet 16. A comment from the blue-ribbon panel (BRP) sums it up: [read more...]
See the Current Standings! | For more on NephMadness 2015 | #NephMadness or #OncoRegion on Twitter Nephron-Sparing Surgery versus Nephrectomy for Renal Cancer Winner: Nephron-Sparing Surgery 6-1 split Taking the kidney out and curing the cancer is a [read more...]
Submit your picks! | For more on NephMadness 2015 | #NephMadness or #OncoRegion on Twitter Onconephrology is wide subject ranging from renal cancers, to side effects from chemo- and radiotherapy to renal paraneoplastic processes like amyloidosis. [read more...]